Assessing genomic radiosensitivity metrics in canine sinonasal tumors

Abstract Background Canine sinonasal tumors exhibit heterogeneous outcomes after radiotherapy. The gene expression-based Radiosensitivity Index (RSI) and its derivative genome-adjusted radiation dose (GARD) have been investigated in human oncology, but their applicability to canine tumors is uncertain. We evaluated associations of canonical RSI, GARD, tumor dose and volume metrics, and custom transcriptional programs with survival in radiotherapy-treated dogs. Methods The retrospective cohort comprised 75 dogs. RNA sequencing was performed on tumor tissue isolated by laser-capture microdissection (LCM) and/or scrolls to determine RSI, GARD and gene expression programs. Cox models evaluated OS, DSS and TTP, with Weight and log (GTV/Nasal) adjustment in 72 complete cases. Results In total, 60 deaths were observed, of which 42 were disease specific. Median OS, DSS and TTP were 500, 695 and 399 days. Canonical RSI and GARD were not associated with any endpoint. Four DNA-repair and cell-cycle-related programs were associated with shorter OS in the full cohort, but this did not remain statistically significant when restricted to carcinoma and sarcoma only. The mitotic index did not correlate with outcome, suggesting limited prognostic utility. In contrast, short survivors showed a trend towards an increased proliferation- and cell cycle checkpoint transcriptional activity, indicating that biologically relevant proliferative signals were not adequately captured by the mitotic index alone. Conclusions Canonical RSI and GARD were not prognostic in our cohort. In contrast, increased DNA repair and cell-cycle related transcriptional activity was associated with poorer outcomes, supporting the potential prognostic value of transcriptomic profiling in canine sinonasal tumors. Independent validation is required before application to clinical decision-making or radiotherapy dose adaption.

Authors

Publication Details

Journal
BMC Cancer
Published
2026-11-17
DOI
https://doi.org/10.1186/s12885-026-17295-2
Primary Topic
Veterinary Oncology Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Assessing genomic radiosensitivity metrics in canine sinonasal tumors

Sergejs Unterkirhers, Enni Markkanen, Daniel Fuchs, Carla Rohrer Bley et al.
BMC Cancer
Veterinary Oncology Research
article

Assessing genomic radiosensitivity metrics in canine sinonasal tumors

Sergejs Unterkirhers, Enni Markkanen, Daniel Fuchs, Carla Rohrer Bley, Maria Moccia, Frauke Seehusen, Carlotta Ahrens, Nina Hungerbühler
article en

Abstract

Abstract Background Canine sinonasal tumors exhibit heterogeneous outcomes after radiotherapy. The gene expression-based Radiosensitivity Index (RSI) and its derivative genome-adjusted radiation dose (GARD) have been investigated in human oncology, but their applicability to canine tumors is uncertain. We evaluated associations of canonical RSI, GARD, tumor dose and volume metrics, and custom transcriptional programs with survival in radiotherapy-treated dogs. Methods The retrospective cohort comprised 75 dogs. RNA sequencing was performed on tumor tissue isolated by laser-capture microdissection (LCM) and/or scrolls to determine RSI, GARD and gene expression programs. Cox models evaluated OS, DSS and TTP, with Weight and log (GTV/Nasal) adjustment in 72 complete cases. Results In total, 60 deaths were observed, of which 42 were disease specific. Median OS, DSS and TTP were 500, 695 and 399 days. Canonical RSI and GARD were not associated with any endpoint. Four DNA-repair and cell-cycle-related programs were associated with shorter OS in the full cohort, but this did not remain statistically significant when restricted to carcinoma and sarcoma only. The mitotic index did not correlate with outcome, suggesting limited prognostic utility. In contrast, short survivors showed a trend towards an increased proliferation- and cell cycle checkpoint transcriptional activity, indicating that biologically relevant proliferative signals were not adequately captured by the mitotic index alone. Conclusions Canonical RSI and GARD were not prognostic in our cohort. In contrast, increased DNA repair and cell-cycle related transcriptional activity was associated with poorer outcomes, supporting the potential prognostic value of transcriptomic profiling in canine sinonasal tumors. Independent validation is required before application to clinical decision-making or radiotherapy dose adaption.

BMC Cancer
Good health and well-being
Veterinary Oncology Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon